Pelitrexol structure
|
Common Name | Pelitrexol | ||
---|---|---|---|---|
CAS Number | 446022-33-9 | Molecular Weight | 463.507 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C20H25N5O6S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of PelitrexolPelitrexol (AG 2037) is an inhibitor of glycinamide ribonucleotide formyltransferase (GARFT). |
Name | N-((5-(2-((6S)-2-Amino-1,4,5,6,7,8-hexahydro-4-oxopyrido[2,3-d]pyrimidin-6-yl)ethyl)-4-methyl-2-thienyl)carbonyl)-L-glutamic acid |
---|---|
Synonym | More Synonyms |
Description | Pelitrexol (AG 2037) is an inhibitor of glycinamide ribonucleotide formyltransferase (GARFT). |
---|---|
Related Catalog | |
Target |
GARFT[1] |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Molecular Formula | C20H25N5O6S |
Molecular Weight | 463.507 |
Exact Mass | 463.152557 |
PSA | 215.74000 |
LogP | -0.58 |
Index of Refraction | 1.743 |
L-Glutamic acid, N-[[5-[2-[(6S)-2-amino-3,4,5,6,7,8-hexahydro-4-oxopyrido[2,3-d]pyrimidin-6-yl]ethyl]-4-methyl-2-thienyl]carbonyl]- |
N-[(5-{2-[(6S)-2-Amino-4-oxo-1,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl}-4-methyl-2-thienyl)carbonyl]-L-glutamic acid |
(2S)-2-(((5-(2-((6S)-2-Amino-4-oxo-1,4,5,6,7,8-hexahydropyrido(2,3-D)pyrimidin-6-yl)ethyl)-4-methylthiophen-2-yl)carbonyl)amino)pentanedioic acid |
Ag2037 |
Pelitrexol |
Unii-dht6E8m4kp |
L-Glutamic acid,N-((5-(2-((6S)-2-amino-1,4,5,6,7,8-hexahydro-4-oxopyrido(2,3-D)pyrimidin-6-yl)ethyl)-4-methyl-2-thienyl)carbonyl) |